BlogOctober 5, 2022 Gregory Roufa and David Glowacki are Building Digital Group Therapeutics – Podcast Episode #20
BlogSeptember 28, 2022 Jordan Tishler is a Physician, Educator, and Patient Advocate – Podcast Episode #19
BlogSeptember 28, 2022 What are the Concerns With Self-Administering Psychedelics?: Mindshifting Moments #12
BlogSeptember 27, 2022 Payton Nyquvest, CEO of Numinus, Sits in the Investor Hotseat on September 29th
BlogSeptember 21, 2022 Algernon Pharmaceuticals Announces Receipt of CDN $450K Cash Refund from Australian Research Program
BlogSeptember 21, 2022 Robbie Bent is Building the Future of Emotional Wellness – Podcast Episode #18
BlogSeptember 13, 2022 What Can Psychedelics Learn From the Cannabis Industry?: Mindshifting Moments #10
BlogSeptember 7, 2022 Douglas Finkelstein Develops Community Around Psychedelics – Podcast Episode #16
BlogAugust 31, 2022 Amanda Reiman Plants Seeds for the Growth of Plant Medicines – Podcast Episode #15
